Clinical Trial Update: Clinical Evaluation of Ujiplus® Against Schistosoma Mansoni [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/3 clinical trial evaluating Ujiplus against Schistosoma mansoni has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schistosomiasis Due to Schistosoma Mansoni

Drugs mentioned

• Ujiplus

Snippet

Sponsor: Kenya Medical Research Institute | Conditions: Schistosoma Mansoni | Phase 2, Phase 3 | Status: COMPLETED